U.S. imports of generic drugs have fallen since the elections. Shipments by sea of the biggest four drug classes fell 3% in February on a year earlier, and by 23% for the three months to February 28 vs. the three months to end-November. That is likely the result of uncertainties around payment schemes due to the Trump administration’s failed attempt to reform the Affordable Care Act. Attention may now move to more direct approaches to cutting drug costs, for example by allowing imports from Canada as suggested by Senators McCain and Grassley. Panjiva analysis of the top 12 generic drug s...